The phase II study of zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL) patients with specific gene-expression
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Qunling Zhang, Shiyu Jiang, Yizhen Liu, Jia Jin, Chuanxu Liu, Wenhao Zhang, Rong Tao, Xiaoyan Zhou, Junning Cao
Institutions: Fudan University, Fudan University Shanghai Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108457141